June 18, 2024

Don’t miss out on the 7th Global Forum on TB Vaccines this October

IAVI is honored to be co-organizing the 7th Global Forum on TB Vaccines at a time of heightened attention to TB vaccine development and implementation.

7th Global Forum on TB Vaccines

We’re less than four months away from the 7th Global Forum on TB Vaccines, taking place for the first time in the Americas in Rio de Janeiro, Brazil, from October 8-10, 2024. This Forum, expected to be the largest edition to date, aims to bring more than 400 stakeholders from over 35 countries and all sectors of the TB vaccine field to Rio de Janeiro. The 7th Global Forum is convened by the Stop TB Partnership Working Group on New TB Vaccines in collaboration with IAVI, the TuBerculosis Vaccine Initiative (TBVI), and hosted by the Ministry of Health of Brazil and the Brazilian Tuberculosis Research Network (REDE-TB).

With its leadership in global health research and biomedical manufacturing, its commitment to ending TB, and its innovative and collaborative spirit, Brazil is an exciting venue for the 7th Global Forum. Brazil has demonstrated this commitment through multisectoral domestic initiatives and by taking leadership roles in global endeavors, including as co-chair for the WHO TB Vaccine Accelerator Council.

“On behalf of the Brazilian government, I am honored to co-chair the 7th Global Forum on TB Vaccines. We look forward to welcoming the global TB vaccine community to Rio de Janeiro in October for this important event,” said Dr. Ethel Maciel, Secretary of Health Surveillance and Environmental Health, Ministry of Health, Brazil, and 7th Global Forum co-chair. “Brazil is steadfast in its commitment to support the development and delivery of new TB vaccines, including including through Dr Nísia Trindade Lima, Minister of Health of Brazil, as co-chair of the WHO TB Vaccine Accelerator Council. Together, we can make new TB vaccines possible and ensure they are accessible to all.”

The theme for the 7th Global Forum on TB Vaccines — “Driving innovation from discovery to access” — speaks to the ingenuity and perseverance advancing the TB vaccine pipeline. The program will cover the full spectrum of research and development (R&D), from basic and discovery research to diversifying the TB vaccine pipeline through clinical research. With multiple candidates now advancing through late-stage clinical trials, the Forum will also explore strategies to ensure new TB vaccines reach and are taken up by the populations that need them most, maximizing their public health impact. their public health impact.

“The 7th Global Forum on TB Vaccines takes place during a pivotal moment in TB vaccine development. This Forum provides an invaluable opportunity to explore the breadth of TB vaccine innovation, from basic science and clinical development, to access, advocacy, and community engagement,” shared Dr. David Lewinsohn, chair, WGNV, USA, and 7th Global Forum co-chair. “We are proud to convene the 7th Global Forum as a platform to foster partnerships, scientific exchange, and momentum to bring new TB vaccines over the finish line.”

Conference committees, representing diverse stakeholders from around the world engaged in TB vaccine R&D, advocacy, access and implementation planning, and other areas of the field, are working with the co-chairs and organizers to develop the Forum program, review abstracts, and provide other valuable input. The dynamic three-day program will feature six plenary sessions, oral and poster presentations, and discussion sessions. Participants will also have the unique opportunity to join site visits on Friday, October 11, 2024, where they will visit research facilities and health care settings and interact with local researchers and care providers.

Registration is now open, with tiered pricing for participants from high-income countries, lower- and middle-income countries, and early bird rates available until July 31. A limited amount of travel and registration support is also available for students, post-docs, early career researchers, advocates, affected communities, and participants from lower- and middle-income countries. Applications are due by June 30, 2024. 

We look forward to welcoming the TB vaccine community to the renowned Cidade das Artes in Rio de Janeiro this October as we reflect on the progress to date, review the latest innovations across the pipeline, and seek out inspiration for the exciting road ahead.

About the Global Forum on TB Vaccines

The Global Forum on TB Vaccines is convened every two to three years by the Stop TB Partnership Working Group on New TB Vaccines (WGNV) in collaboration with IAVI, TuBerculosis Vaccine Initiative (TBVI), and a partner in the host country. The Global Forum is the world’s largest gathering of TB vaccine stakeholders and allows researchers, clinicians, product developers, policymakers, civil society, and affected community groups to take stock of advances in the field, exchange perspectives on the latest research and best practices, and define priority actions aimed at accelerating the development of new TB vaccines.